St. John's Wart (SJW) and morphine and narcan.
SJW is listed as a MAOI inhibitor. The stipulated mechanism of action is that it blocks the reuptake of neurotransmitters (monoamines) potentiating their time and effect in the synaptic cleft.
That makes the goal of treatment to increase stimulation and it is used as a last line effort to treat clinical depression.
Morphine inhibits presynaptic neurotransmitter release, acting as a depressant.
With all known effects and excluding some yet unknown or undocumented reaction, taken together, morphine would prevent release and SJW would prevent reuptake. Depending on the half life, affinity, and potency, the reasonable conclusion is one would cancel the other or reduce the effectiveness of one or both.
I have searched the NIH, FDA, both my pharmacology texts, Medscape, and google. I can find no compelling information or even a suggestion there is an interaction at the synapses between morphine and MAOIs. Though several other opioids do have known reactions. (see my earlier post) I did find a study on medscape listing a study done by a manfufacturer of time release PO morphine stating there may be an adverse reaction. However, the link has been removed.
I also found information that demonstrates that both morphine and St. John's wart are metabolized by cytochrome p450 (multienzyme oxidases) and as such inhibit each other's clearance nd potentiate (lenghten) the affects of each other.
High dose or repeated administration could conceivably raise bioavailability of morphine and cause the toxic effects associated. (respiratory depression, hypotension, altered mental status)
Liver damage or infection could also reduce the availability of the CYP further adding to the amount of active drug.
It is also logical that this could be compounded in a patient further with hypersensitivity to opioids.
When adding narcan to the mix, like any competative inhibitor, if the amount of bioactive morphine was elevated, it would increase the probability of morphine blocking the narcan (standard saturation kinetics) reducing the effectiveness and theraputic level of the narcan. A rapid reversal of the opioid without an elevated dose of narcan seems highly unlikely, using anything that is currently known about biochemistry and the properties of the agents involved.